ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
4,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
5,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
5,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
5,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5,6,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
5,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
5,8,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
5,9,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5,10,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,11,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
6,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
6,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
6,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
6,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6,5,Myopathy,Myopathies,Muscle disorders,Musc,N
6,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
12,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
12,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
12,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
12,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
13,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
13,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
15,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
16,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
17,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
19,1,Central nervous system inflammation,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
19,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
19,4,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
19,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
19,6,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
19,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
19,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,9,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
20,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
21,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
21,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
21,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
22,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
23,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
23,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
23,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
27,2,Polydactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
28,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
29,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
30,3,Migraine,Migraine headaches,Headaches,Nerv,N
30,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,5,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
31,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
31,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
31,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
31,4,Vesicoureteric reflux,Bladder reflux conditions,Bladder and bladder neck disorders (excl calculi),Renal,N
32,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
32,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
33,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
33,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
33,3,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
33,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
34,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
35,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
36,1,Chlamydial infection,Chlamydial infections,Chlamydial infectious disorders,Infec,N
36,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
36,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
36,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
36,5,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
37,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
37,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
37,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
37,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
38,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
38,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
38,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
39,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,2,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
40,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
42,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
45,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
45,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
46,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
48,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
49,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
50,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
51,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
51,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
52,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
52,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
53,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
54,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
54,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
56,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
56,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
56,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
56,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
56,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
56,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
56,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
56,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,10,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
57,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
58,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
58,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
58,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
58,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
58,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
58,9,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
58,10,Weight loss poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
59,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
60,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
61,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
62,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
63,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
64,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
65,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
66,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
66,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
67,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
68,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
68,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
68,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
69,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
70,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
71,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
71,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
73,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
76,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
76,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
77,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
78,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
78,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
79,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
79,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
80,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
80,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
81,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
82,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
82,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
83,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
83,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
84,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
